Monthly Archives: May 2002






Psychiatrist’s Undisclosed Financial Ties Prompt Reproval – NYT Sun, 3 Aug 2003 The New York Times reports that Dr. Charles Nemeroff, head of psychiatry and behavioral sciences at Emory School of Medicine (Atlanta) has been rebuked by colleagues for failing to disclose his substantial financial ties to drug companies whose […]

Psychiatrist's Undisclosed Financial Ties Prompt Reproval – NYT


Bitter Pill for David Healy: academia under pharma influence May 21, 2002 One wonders how many embarrassing causes celebres are needed before academic institutions take back control of the university from the corrosive influence of the pharmaceutical/ biotech industry? In 2000, Dr. David Healy may have been surprised by the […]

Bitter Pill for David Healy: academia under pharma influence


Harvard research in China: Open Letter to Pres. Summers Sat, 12 Apr 2003 On May 15, 2002, The Boston Globe reported that Lawrence Summers, the President of Harvard University, “expressed deep regret that a dozen Harvard-run genetic studies in China failed to give test subjects adequate information about potential pitfalls.” […]

Harvard research in China: Open Letter to Pres. Summers



Dissenting Opinion (NHRPAC Children Workgroup) re: Proposed Reinterpretation of Fed. Regs Protecting Children (45 CFR 46, sections 404 and 406) May 14, 2002 To: Alan Fleischman, MD, Chair, Children’s Workgroup of NARPAC        Mary Faith Marshall, Ph.D., Chair, NARPAC From: Vera Hassner Sharav Re: Dissenting Opinion re: Report to NHRPAC, proposing […]

Dissenting Opinion – Proposed Children's Workgroup Reinterpretation of Fed Regs ...


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav May 13, 2002 Experimentationon Newborns: Is it Ethical? FYI The Wall Street Journal reported: "Oneoutrage now before a court has stunned even bioethicists who thought they’d seenit […]

InfoMail for May 13, 2002


Presented by Vera Hassner Sharav
14th Tri-Service Clinical Investigation Symposium
Sponsored by The U.S. Army Medical Department and The Henry M. Jackson Foundation for the Advancment of Military Medicine

The cornerstone of public trust in medical research is the integrity of academic institutions and the expectation that universities, which rely on public funding, have a responsibility to serve the public good. Financial conflicts of interest affect millions of American people - those who are subjects of clinical trials testing new drugs and those who are prescribed drugs after their approval.

Conflicts of Interest in Clinical Trials



CONFLICTS OF INTEREST Presented by Vera Hassner Sharav 14th TRI-SERVICE CLINICAL INVESTIGATION SYMPOSIUM Sponsored By THE U.S. ARMY MEDICAL DEPARTMENT And THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCMENT OF MILITARY MEDICINE May 5-7, 2002 The cornerstone of public trust in medical research is the integrity of academic institutions and […]

Sharav Presentation before US Army Medical Dept., May 6, 2002